首頁 > 市場調查報告書 > 醫療設備

體外診斷

照護現場血糖監測市場規模、佔有率及成長分析（按類型、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898607

照護現場血糖監測市場規模、佔有率及成長分析（按類型、應用、最終用戶和地區分類）－2026-2033年產業預測

Point-of-care Glucose Testing Market Size, Share, and Growth Analysis, By Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，照護現場血糖監測市場規模將達到 35.8 億美元，到 2025 年將達到 37.4 億美元，到 2033 年將達到 51.9 億美元，預測期（2026-2033 年）的複合年成長率為 4.2%。

由於糖尿病發病率不斷上升以及定期血糖監測的重要性日益凸顯，照護現場血糖監測市場正經歷顯著成長。攜帶式監測設備可提供即時結果，使醫護人員和患者都能在護理現場便捷地管理血糖值。其主要優點包括：能夠及時獲取資訊以製定合適的治療方案、改善患者預後以及降低整體成本。然而，設備精度、干擾因素和高成本等挑戰可能會限制部分使用者的使用。生物感測器技術的創新及其與數位健康平台的融合為市場拓展提供了機會。最終，該領域的目標是幫助人們有效管理糖尿病，從而改善全球的健康狀況和疾病管理策略。

照護現場血糖監測市場促進因素

全球糖尿病盛行率的不斷上升是推動照護現場血糖監測市場成長的主要因素。隨著越來越多的糖尿病患者被確診，持續血糖監測已成為有效疾病管理的迫切需求。由於越來越多的人需要定期檢測以維持健康，對就地檢驗設備的需求持續成長。這種變化凸顯了便捷高效的監測解決方案的重要性，推動了市場創新和擴張，醫療保健系統也致力於改善這種慢性疾病患者的治療效果。

限制照護現場血糖監測市場的因素

照護現場血糖監測設備及其耗材的高成本是市場擴張的一大障礙。在醫療資源匱乏、可支配所得普遍較低的發展中地區，此價格問題尤其突出。因此，這些檢測設備的高價可能會阻礙其廣泛應用，尤其是在低收入者和預算緊張的醫療機構中。這種限制可能會降低照護現場血糖檢測的可及性和使用率，最終影響整個市場的成長。

照護現場血糖監測市場趨勢

照護現場血糖監測市場正呈現出一個顯著的趨勢，即把測量設備與數位健康平台和電子健康記錄（EHR）系統整合起來。這種整合方式實現了無縫資料傳輸和即時血糖值監測，從而提高了患者參與糖尿病管理的動機。患者可以更有效地追蹤血糖值，而醫療專業人員則可以獲得全面的數據，以便做出更明智的治療決策。這種技術與醫療的協同作用不僅提高了糖尿病整體診療的效率，還有助於個人化醫療的發展，最終改善患者的健康狀況，並促進積極主動的糖尿病管理。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Roche Holding AG（Switzerland）
Ascensia Diabetes Care Holdings AG（Switzerland）
Dexcom, Inc.（USA）
Medtronic plc（Ireland）
LifeScan, Inc.（USA）
Becton, Dickinson and Company（BD）（USA）
ACON Laboratories, Inc.（USA）
Nova Biomedical Corporation（USA）
ARKRAY, Inc.（Japan）
Trividia Health, Inc.（USA）
PTS Diagnostics（USA）
Nipro Corporation（Japan）
Ypsomed Holding AG（Switzerland）
Sanofi SA（France）
EKF Diagnostics Holdings plc（UK）
Prodigy Diabetes Care, LLC（USA）
Bayer AG（Germany）
Danaher Corporation（USA）
Platinum Equity Advisors, LLC（USA）

結論與建議

簡介目錄

Product Code: SQMIG15E2398

Point-of-care Glucose Testing Market size was valued at USD 3.58 Billion in 2024 and is poised to grow from USD 3.74 Billion in 2025 to USD 5.19 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The point-of-care glucose testing market is experiencing substantial growth, driven by the rising incidence of diabetes and the critical need for regular glucose monitoring. Portable testing devices enable immediate results, allowing both healthcare professionals and patients to conveniently monitor blood glucose levels at the point of care. Key benefits include timely insights for informed treatment decisions, improved patient outcomes, and overall cost reduction. However, challenges such as device accuracy, interferences, and high costs may limit accessibility for some users. Innovations in biosensor technology and integration with digital health platforms present opportunities for market expansion. Ultimately, this sector aims to empower individuals to manage diabetes effectively, enhancing global health outcomes and disease management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Point-of-care Glucose Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Point-of-care Glucose Testing Market Segments Analysis

Global Point-Of-Care Glucose Testing Market is segmented by type, application, end user and region. Based on type, the market is segmented into lancing devices and strips and blood-glucose meter. Based on application, the market is segmented into type-1 diabetes and type-2 diabetes. Based on end user, the market is segmented into hospitals and clinics, home care settings and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Point-of-care Glucose Testing Market

A significant catalyst for the growth of the point-of-care glucose testing market is the rising prevalence of diabetes worldwide. The escalating number of individuals diagnosed with diabetes creates a pressing need for consistent glucose monitoring to manage the condition effectively. As more people require regular testing to maintain their health, the demand for point-of-care testing devices continues to increase. This shifting landscape emphasizes the importance of accessible and efficient monitoring solutions, driving innovation and expansion within the market as healthcare systems strive to improve outcomes for those affected by this chronic illness.

Restraints in the Point-of-care Glucose Testing Market

The high cost associated with point-of-care glucose testing devices and their consumables poses a significant barrier to the expansion of the market. This affordability issue is particularly pronounced in developing regions where healthcare resources are scarce and disposable incomes are generally lower. As a result, the elevated prices of these testing devices can impede their broader acceptance, especially among low-income populations and healthcare institutions operating within tight budgetary limits. Consequently, this limitation can restrict the accessibility and utilization of point-of-care glucose testing, ultimately affecting overall market growth.

Market Trends of the Point-of-care Glucose Testing Market

The Point-of-care Glucose Testing market is witnessing a notable trend toward the integration of testing devices with digital health platforms and electronic health records. This cohesive approach facilitates seamless data transfer and real-time glucose level monitoring, thereby enhancing patient engagement in diabetes management. Patients can now track their glucose levels more effectively, while healthcare professionals gain access to comprehensive data for informed treatment decisions. This synergy between technology and healthcare not only improves the overall efficiency of diabetes care but also supports personalized medicine, ultimately driving better health outcomes and fostering a proactive approach to managing diabetes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Point-Of-Care Glucose Testing Market Size by Type & CAGR (2026-2033)

Market Overview
Lancing Devices and Strips
Blood-Glucose Meter

Global Point-Of-Care Glucose Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Type-1 Diabetes
Type-2 Diabetes

Global Point-Of-Care Glucose Testing Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Home Care Settings
Others

Global Point-Of-Care Glucose Testing Market Size & CAGR (2026-2033)

North America (Type, Application, End User)
- US
- Canada
Europe (Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trividia Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PTS Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics Holdings plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prodigy Diabetes Care, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Platinum Equity Advisors, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments